Wednesday, December 22, 2010

Medical News

Medical News


Most Medicare stroke patients dead or readmitted within 1 year

Posted: 22 Dec 2010 04:00 PM PST

A study of US Medicare patients with ischemic stroke has found that nearly two-thirds of those who survive to hospital discharge are rehospitalized or die within 1 year.

Apolipoprotein A-IV protein possible target for allergic rhinitis treatment

Posted: 22 Dec 2010 04:00 PM PST

Japanese researchers have identified a new target molecular for the treatment of seasonal allergic rhinitis.

Empathy deteriorates with illness progression in schizophrenia

Posted: 22 Dec 2010 04:00 PM PST

Patients with first-episode psychosis show relatively preserved empathy, which appears to deteriorate with progression to more chronic schizophrenia, perhaps as a consequence of cognitive decline, study results show.

Bipolar disorder with BPD marked by high aggression and impulsivity

Posted: 22 Dec 2010 04:00 PM PST

Bipolar disorder patients with comorbid borderline personality disorder show a heightened level of impulsivity and aggression as well as a markedly elevated rate of suicide attempts relative to those with bipolar disorder alone, study results show.

Prostate cancer risk calculator underestimates high-grade disease

Posted: 22 Dec 2010 04:00 PM PST

Caution is required when applying the prostate cancer risk calculator to patients with suspected prostate cancer as it may underestimate their risk for high-grade disease, warn US researchers.

PSA bounce after brachytherapy do not always indicate biochemical failure

Posted: 22 Dec 2010 04:00 PM PST

Prostate cancer patients treated with brachytherapy should be informed of the potential for a prostate-specific antigen "bounce" after treatment, to "allay unnecessary worry" that they are experiencing recurrence of disease, say Australian researchers.

Early liver, heart damage found in children with metabolic syndrome

Posted: 22 Dec 2010 04:00 PM PST

Children with the metabolic syndrome are at increased risk for preclinical manifestations of liver and cardiac damage, Italian researchers have shown.

Fenofibrate therapy reduces burden of oxidative stress

Posted: 22 Dec 2010 04:00 PM PST

Treatment with fenofibrate leads to a reduction in biomarkers of oxidative stress, US researchers have shown.

Telemonitoring program leads to weight loss and improved glycemic control in Type 2 diabetes

Posted: 22 Dec 2010 04:00 PM PST

A weight-loss program combining diet, exercise, and telemonitoring, and only moderate cost can offer multiple benefits for patients with Type 2 diabetes, a small trial suggests.

Insulin resistance link with CRP independent of abdominal obesity

Posted: 22 Dec 2010 04:00 PM PST

Chinese researchers have found evidence to suggest that abdominal obesity only partly explains the link between subclinical inflammation and insulin resistance.

Novel ARIC risk score predicts AF risk in Black, White individuals

Posted: 22 Dec 2010 04:00 PM PST

US researchers report that a recently developed tool may reliably predict the 10-year risk for new-onset atrial fibrillation in Black or White individuals.

Codeine therapy in elderly may pose CV risk

Posted: 22 Dec 2010 04:00 PM PST

Using codeine for more than 6 months may increase the risk for cardiovascular events and all-cause mortality in patients aged 70 years or older, study findings suggest.

Social wellbeing linked to improved breast cancer outcome

Posted: 21 Dec 2010 04:00 PM PST

Social wellbeing in the first 6 months after a breast cancer diagnosis is significantly associated with a decreased risk for recurrence and death from the disease after treatment, research shows.

<i>Trans</i>-palmitoleic acid consumption linked to reduced Type 2 diabetes risk

Posted: 21 Dec 2010 04:00 PM PST

Consumption of trans-palmitoleate, a component of dairy products not produced by the body, reduces insulin resistance and incidence of diabetes, report US researchers.

Factors associated with HbA1c target attainment in Type 2 diabetes clarified

Posted: 21 Dec 2010 04:00 PM PST

Study results show that ethnicity, duration of diabetes, baseline demographics, and ongoing pharmacotherapy, but not access to private drug insurance coverage, all influence glycated hemoglobin target attainment in Type 2 diabetes.

No comments:

Post a Comment